Fingerprint
Dive into the research topics where Hiroshi Morinaga is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease
Imaizumi, T., Yokota, T., Funakoshi, K., Yasuda, K., Hattori, A., Morohashi, A., Kusakabe, T., Shojima, M., Nagamine, S., Nakano, T., Huang, Y., Morinaga, H., Ohta, M., Nagashima, S., Inoue, R., Nakamura, N., Ota, H., Maruyama, T., Gobara, H. & Endoh, A. & 3 others, , May 2025, In: Clinical and Experimental Nephrology. 29, 5, p. 650-661 12 p., e0236132.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of a mobile health application on self-management among Japanese patients with chronic kidney disease
Suetsugu-Ishizawa, R., Sakuma, H., Matsuki, M., Itano, S., Nagasu, H., Morinaga, H., Uchida, H. A., Kuwabara, T., Imasawa, T., Yamada, K. & Nakagawa, N., Oct 2025, In: Clinical and Experimental Nephrology. 29, 10, p. 1354-1362 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Case series showing the safety and changes in lipid profiles of hemodialysis patients with hypertriglyceridemia after pemafibrate administration
Okada, R., Onishi, Y., Kobayashi, N., Ishihara, H., Yokoyama, T., Mifune, T., Sakurabu, Y., Nojima, I., Morinaga, H., Uchida, H. A. & Wada, J., Dec 2024, In: Renal Replacement Therapy. 10, 1, 74.Research output: Contribution to journal › Article › peer-review
Open Access -
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
The EMPA-KIDNEY Collaborative Group, Jan 2024, In: The Lancet Diabetes and Endocrinology. 12, 1, p. 39-50 12 p.Research output: Contribution to journal › Article › peer-review
Open Access77 Link opens in a new tab Citations (Scopus) -
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
The EMPA-KIDNEY Collaborative Group, Jan 2024, In: The Lancet Diabetes and Endocrinology. 12, 1, p. 51-60 10 p.Research output: Contribution to journal › Article › peer-review
Open Access85 Link opens in a new tab Citations (Scopus)